250mg Bdron Abiraterone Acetate Tablet About
Experience triumphant cancer care with Bdron Abiraterone Acetate 250mg Tablets, the must-have solution for advanced oncology needs. Now available at a remarkable reduced price, these tablets bring incomparable savings to your pharmaceutical requirements. Marketed by Professional Pharmaceuticals, each box contains 120 white, film-coated, oval tablets-expertly manufactured as a potent CYP17 inhibitor for oral use in prostate and blood cancers, as well as sickle cell anemia. Odorless and easy to store below 30C, each blister pack is crafted to ensure quality and long-lasting efficacy (shelf life: 24 months).
Comprehensive Oncology Care Tablet - Key Highlights
Bdron Abiraterone Acetate 250mg Tablets are specially developed for oral administration in oncology, particularly targeting prostate and blood cancers. With the power of Abiraterone Acetate as its active component, this film-coated tablet offers potent CYP17 inhibition for superior effectiveness. Packaged in boxes of 120, each oval-shaped, white tablet is odorless and preserved in a dry place below 30C. The product stands out for its exceptional reliability and advanced pharmaceutical grade.
Expansive Domestic and Global Supply - Hassle-Free Delivery
Handed over with careful packaging, Bdron Abiraterone Acetate 250mg Tablets are available for prompt delivery throughout India and key export markets globally. Supported by Professional Pharmaceuticals' strong supply ability, seamless exchange and efficient logistics ensure timely and safe arrival at your location. Main domestic and international customers benefit from robust distribution, making this product a preferred choice for clinics, pharmacies, and traders seeking trustworthy oncology medication supply solutions.
FAQ's of 250mg Bdron Abiraterone Acetate Tablet:
Q: How should Bdron Abiraterone Acetate 250mg tablets be administered?
A: Bdron Abiraterone Acetate 250mg tablets are designed for oral use and should be taken exactly as prescribed by your healthcare provider, typically in conjunction with other medications for optimal therapeutic effect.
Q: What makes Bdron Abiraterone Acetate 250mg tablets remarkable in cancer treatment?
A: These tablets act as a potent CYP17 inhibitor, providing superior and targeted action against prostate cancer, blood cancer, and sickle cell anemia, making them an invaluable component in oncology therapy.
Q: When can I expect the product to be delivered after placing an order?
A: Delivery timelines depend on your location and stock availability; however, Professional Pharmaceuticals prioritizes swift and secure delivery processes to ensure timely handover for both domestic and international orders.
Q: Where is Bdron Abiraterone Acetate 250mg tablet available for purchase?
A: The tablets are available through licensed exporters, suppliers, and traders within India, as well as through international partners catering to multiple global markets.
Q: What is the shelf life and ideal storage condition for these tablets?
A: Bdron Abiraterone Acetate 250mg tablets have a shelf life of 24 months. They should be stored below 30C in a dry, odorless environment, inside their original blister packaging to maintain potency and stability.